All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
The McGee Eye Institute ophthalmology residents reviewed “Use of intracameral antibiotics prophylaxis in patients with posterior capsular rupture during cataract surgery: a systematic review and meta-analysis” from the Journal of Cataract & Refractive Surgery.
Detecting irregular astigmatism early has taken on greater importance, particularly in the context of cataract surgery planning and patient satisfaction. Understanding how these findings are detected and why they matter clinically is becoming an essential part of preoperative evaluation, according to sources who weighed in on the topic.
➤ 24-month pivotal data support efficacy of laser treatment for glaucoma
➤ Low-dose atropine drop meets primary, secondary endpoints in new data analysis
➤ Phase 2 topline data for modifier gene therapy for geographic atrophy
➤ Phase 2 data from study evaluating neuropathic corneal pain shows quality of life improvement
➤ New shelf-stable corneal endothelial cell therapy program begins
➤ ASCRS news and events
Having varying degrees of zonulopathy can make a case more challenging. Two surgeons discussed what they look for to determine if a patient has some form of zonulopathy, the best lenses and tools to use in these cases, and other important approaches to proceeding with surgery.
➤ FDA approves new EDOF with limited dysphotopsias
➤ Phase 1/2 12-month data for IOL-based drug delivery system
➤ Topline results from Phase 2a wet AMD study
➤ FDA grants Breakthrough Device Designation to brain implant technology
➤ FDA allows Phase 1/2 trial to begin for investigational cell therapy for familial drusen
➤ ASCRS news and events
➤ First patient treated with novel crosslinking approach for refractive error
➤ Multisociety working group established to set guidelines for modern IOL classification
➤ FDA reduces clinical trial requirement for new drugs to one pivotal trial
➤ ASCRS news and events
➤ Enrollment complete in first-in-human trial evaluating treatment for patients with Usher syndrome
➤ First patients randomized in drug-eluting IOL trial
➤ Preliminary data from Phase 2 gene modifier study for geographic atrophy
➤ ASCRS news and events
➤ FDA accepts BLA for thyroid eye treatment
➤ Breakthrough Therapy Designation granted to investigational neuroprotective for optic neuropathies
➤ FDA issues complete response letter for wet AMD BLA resubmission
➤ Biosimilar approved for retinal therapies
➤ FDA approves IND for corneal genome editing program
➤ Study: ‘largest prospective trial ever’ on postcataract endophthalmitis prophylaxis
➤ Complimentary access to video journal
➤ Company news
➤ ASCRS news and events
When considering cataract surgery, one of the most basic steps is choosing the incision to be used. EyeWorld spoke to several experts about the impact of these incisions, sizing considerations, and important techniques and principles to ensure a successful surgery.
While not a common approach or its primary indication, the ICL (STAAR Surgical) can be used as a supplementary/piggyback IOL in some patients. Three physicians discussed how this off-label approach to using the ICL is opening doors to treat certain patients.
